tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

AN2 Therapeutics Inc

ANTX
Add to Watchlist
4.920USD
0.0000.00%
Close 07-24 16:00（ET）Quotes delayed by 15 min
134.67MMarket Cap
LossP/E TTM

AN2 Therapeutics Inc

4.920
0.0000.00%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ANTX Financials

See AN2 Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

AN2 Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.29/-0.23
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.16
32.34%
Analyst Rating
STRONG BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
16.91%-0.29
-13.98%-0.29
27.68%-0.31
55.75%-0.21
36.54%-0.35
55.61%-0.25
34.43%-0.43
40.29%-0.48
29.37%-0.56
7.13%-0.57
---0.65
---0.81
---0.79
---0.61
---2.21
----
----
Net Profit
5.83%-10.03M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-42.70%-16.90M
-47.34%-16.71M
-56.17%-15.80M
-61.72%-15.32M
---11.84M
---11.34M
---10.12M
---9.47M
Income Statement
Operating profit
8.55%-10.55M
-8.24%-9.32M
14.71%-10.04M
54.56%-7.22M
36.94%-11.54M
54.25%-8.61M
35.25%-11.77M
4.34%-15.88M
-14.07%-18.30M
-50.81%-18.82M
-54.46%-18.18M
-60.66%-16.60M
-108.76%-16.04M
---12.48M
---11.77M
---10.33M
---7.68M
Net Profit
5.83%-10.03M
-15.79%-8.71M
26.63%-9.35M
55.23%-6.46M
35.92%-10.65M
55.49%-7.52M
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-42.70%-16.90M
-47.34%-16.71M
-56.17%-15.80M
-61.72%-15.32M
---11.84M
---11.34M
---10.12M
---9.47M
Balance Sheet
Current assets
25.78%87.49M
-30.52%59.94M
-34.47%64.02M
-37.15%67.52M
-40.20%69.56M
-21.94%86.26M
-22.72%97.69M
9.40%107.44M
28.78%116.31M
12.05%110.51M
17.81%126.41M
-15.97%98.21M
-24.60%90.32M
--98.62M
--107.30M
--116.88M
--119.78M
Total current liabilities
-30.60%5.56M
-14.83%8.72M
-31.54%6.86M
-31.05%6.98M
-24.84%8.01M
-27.10%10.24M
-32.50%10.02M
-9.26%10.13M
24.48%10.66M
95.42%14.04M
234.81%14.84M
169.00%11.16M
68.39%8.57M
--7.19M
--4.43M
--4.15M
--5.09M
Total assets
7.56%87.49M
-32.73%61.95M
-31.17%67.23M
-30.10%75.83M
-32.92%81.34M
-33.63%92.09M
-36.49%97.69M
9.66%108.48M
33.13%121.26M
35.28%138.74M
39.82%153.81M
-17.57%98.93M
-24.41%91.08M
--102.56M
--110.01M
--120.02M
--120.50M
Total liabilities
-28.48%5.73M
-13.17%8.89M
-31.54%6.86M
-31.05%6.98M
-24.84%8.01M
-27.10%10.24M
-32.50%10.02M
-9.27%10.13M
24.47%10.66M
95.37%14.04M
234.59%14.84M
168.77%11.16M
68.21%8.57M
--7.19M
--4.43M
--4.15M
--5.09M
Total equity
11.50%81.76M
-35.17%53.06M
-31.13%60.38M
-30.01%68.84M
-33.70%73.33M
-34.36%81.85M
-36.91%87.67M
12.07%98.35M
34.03%110.60M
30.75%124.70M
31.63%138.97M
-24.25%87.76M
-28.50%82.52M
--95.37M
--105.57M
--115.86M
--115.41M
Cash Flow Statement
Net operating income
-13.64%-12.07M
0.70%-5.24M
46.91%-6.38M
47.17%-7.60M
39.61%-10.62M
69.11%-5.27M
-1.75%-12.01M
-12.16%-14.38M
-51.72%-17.59M
-123.46%-17.07M
-24.38%-11.80M
-33.65%-12.82M
-72.00%-11.60M
---7.64M
---9.49M
---9.60M
---6.74M
Net investment
-9.82%8.29M
204.27%7.17M
-67.36%6.11M
-64.56%5.83M
-65.03%9.19M
-1738.10%-6.88M
129.97%18.72M
108.96%16.46M
141.48%26.29M
-93.06%420.00K
-2595.81%-62.46M
119.95%7.88M
-22.11%10.89M
--6.05M
---2.32M
---39.49M
--13.98M
Net financing
57329.23%37.33M
--0.00
108.70%48.00K
--0.00
-81.38%65.00K
100.00%0.00
-99.97%23.00K
-100.00%0.00
75.38%349.00K
---321.00K
660760.00%66.07M
165.39%19.05M
-99.69%199.00K
--0.00
---10.00K
--7.18M
--63.19M

FAQs

What are the current assets of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its current assets were 59.94M, with a year-on-year change of -30.52.

What are the total assets of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its total assets of AN2 Therapeutics Inc were 61.95M, with a year-on-year change of -32.73.

What are the total liabilities of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its total liabilities of AN2 Therapeutics Inc were 8.89M, with a year-on-year change of -13.17.

What is the total equity of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its total equity of AN2 Therapeutics Inc was 53.06M, with a year-on-year change of -35.17.

What is the net operating income of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its net operating income of AN2 Therapeutics Inc was -38.11M, with a year-on-year change of 30.14.

What is the net investment of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its net investment of AN2 Therapeutics Inc was 28.31M, with a year-on-year change of -48.14.

What is the net financing of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its net financing of AN2 Therapeutics Inc was 113.00K, with a year-on-year change of -69.62.

What is the Earnings Per Share (EPS) of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.16, with a year-on-year change of 32.34.

What is the net income of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its net income was -35.17M, with a year-on-year change of 31.46.

What is the Return on Equity (ROE) of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -52.14, with a year-on-year change of -4.93.

What is the Return on Assets (ROA) of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.67, with a year-on-year change of -2.71.

What is the operating profit of AN2 Therapeutics Inc?

According to AN2 Therapeutics Inc's FY2025 earnings report, its operating profit was -38.11M, with a year-on-year change of 30.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy